Penumbra, Inc. Securities Litigation

If you purchased a significant amount of shares of Penumbra Inc. Common Stock (NYSE: PEN), you have certain options. Investors should register for updates.

 

Lawsuit Overview

Defendant:Penumbra Inc. Common Stock
Date Filed:January 15th, 2021
Sector:Health Care
Industry:Medical/Dental Instruments
Class Start Date:August 3rd, 2020
Class End Date:December 15th, 2020

According to the Complaint, Penumbra, Inc. is a global healthcare company that develops, manufactures and sells innovative medical devices for patients suffering from stroke and other vascular and neurovascular diseases. Penumbra was the first company to market aspiration catheters, a specialized catheter designed to remove blood clots from arteries and veins in stroke patients, in a surgical procedure known as a thrombectomy.

Until recently, one of the Company's flagship products was the "Jet 7 Xtra Flex," an aspiration. In mid-2020, concerns about the Jet 7 Xtra Flex's safety began to emerge. Despite these concerns, Penumbra repeatedly assured investors during the Class Period that the Jet 7 Xtra Flex was "absolutely safe," "exactly what we hoped it would be," and "not a product that has any possibility of needing to be recalled."

The Complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose material adverse facts about the Jet 7 Xtra Flex's safety, as well as the Company's business, operations, and prospects. Among other things, the Complaint alleges Defendants failed to disclose to investors: (1) that the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use; (2) that Penumbra did not adequately address the risk of Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred; (3) that the Jet 7 Xtra Flex was likely to be recalled due to its safety issues; and (4) as a result, Penumbra's public statements as set forth above were materially false and misleading at all relevant times.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Penumbra Inc. Common Stock

 
First Identified Complaint

Charles Wililams, et al. v. Penumbra, Inc., et al.

Date Filed:January 15th, 2021
Class Period Start:August 3rd, 2020
Class Period End:December 15th, 2020
First Identified Complaint Filings
#Document TitleFiling Date